VitaNova Life Sciences VNOV
OTC VNOV
$4.25 -0.30 (-6.59%)
At close: Oct 22, 2026 · 4:00 PM EDT

VitaNova Life Sciences (VNOV) Gains from Equity Investments (2019)

Updated

VitaNova Life Sciences' Gains from Equity Investments was $15,350 in fiscal Q3 2018 (quarter ended Oct 31, 2017).

Analysis

VitaNova Life Sciences (VNOV) Gains from Equity Investments (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Accenture 152.43 Bn 111.71 Bn 6.13 Bn
2 Cintas 89.87 Bn 88.95 Bn 1.55 Bn
3 Iron Mountain 32.78 Bn 31.97 Bn 1.07 Bn
4 APi 17.10 Bn 14.14 Bn 703.00 Mn
5 Rollins 16.67 Bn 16.22 Bn 582.90 Mn
6 Gartner 15.33 Bn 9.02 Bn 1.19 Bn
7 UL Solutions 14.83 Bn 13.59 Bn 417.00 Mn
8 Aramark 13.83 Bn 11.78 Bn 430.34 Mn
9 Rentokil Initial 11.49 Bn 5.00 Bn -
10 VitaNova Life Sciences 35.43 Mn 29.80 Mn 30,521.00
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2019 -36,696.00
API Access

VitaNova Life Sciences Gains from Equity Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=VNOV&period=max&api_key=YOUR_API_KEY